Actively Recruiting
A Food-Effect Study of CX11 in Healthy Participants
Led by Vincentage Pharma Co., Ltd · Updated on 2026-03-27
32
Participants Needed
1
Research Sites
30 weeks
Total Duration
On this page
Sponsors
V
Vincentage Pharma Co., Ltd
Lead Sponsor
C
Corxel Pharmaceuticals
Collaborating Sponsor
AI-Summary
What this Trial Is About
This study is to evaluate the food effect (FE) on the PK of 200 mg CX11 in healthy participants
CONDITIONS
Official Title
A Food-Effect Study of CX11 in Healthy Participants
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Understand the study's purpose, methods, and possible side effects; able to communicate well; willing to participate and comply with study requirements; and able to sign informed consent
- Weight at least 50.0 kg for men and 45.0 kg for women
- Body mass index (BMI) between 20.0 kg/m2 and less than 28 kg/m2 at screening and on Day 21
You will not qualify if you...
- History of allergy to CX11, similar compounds, or related ingredients, or atopic allergic diseases
- Experienced any significant acute diseases during screening or within 2 weeks before first dose
- Pre-existing conditions affecting gastrointestinal anatomy or motility, liver or kidney function that might affect drug processing, or plans for surgery during the study
- Clinically significant chronic diseases affecting respiratory, cardiovascular, urinary, blood, endocrine, immune, or digestive systems, including fatty liver disease or metabolic dysfunction-associated steatohepatitis
- History of thyroid dysfunction requiring medication or abnormal thyroid stimulating hormone (TSH) levels at screening or Day 21
- Vaccinated within 30 days before screening or planning vaccination during the study
- Participated in another clinical study and received investigational treatment within 90 days or 5 elimination half-lives before screening
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Shanghai Xuhui Central Hospital
Shanghai, Shanghai Municipality, China
Actively Recruiting
Research Team
W
Wang
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
CROSSOVER
Primary Purpose
BASIC_SCIENCE
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here